noon tirzepatide FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price Tirzepatide for Weight Loss |

GLP-1 Beyond Weight Loss: Cardiometabolic and Systemic Benefits The most compelling evidence for GLP-1 extends beyond weight loss

Free radicals may contribute to oxidative skeletal muscle fatigue

For many Canadians, starting with approved options like Tirzepatide or Semaglutide while monitoring Retatrutides regulatory progress makes practical sense

Additional nutrient support for energy, sleep, and recovery

(The mechanism is still being clarified.) Risks, limits, and who should not use them GLP-1s can cause GI side effects (nausea, vomiting), are contraindicated in certain endocrine conditions, and can interact with other medications

If you took reference photos at week 0, the comparison at week 68 shows clear change